UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis

Respiratory medicine, 2010-07, Vol.104 (7), p.1035-1041

2010

Volltextzugriff (PDF)

Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation

The Journal of heart and lung transplantation, 2010-10, Vol.29 (10), p.1159-1164

2010

Volltextzugriff (PDF)

Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis

Respiratory medicine, 2008-09, Vol.102 (9), p.1305-1310

2008

Volltextzugriff (PDF)

Parameters of donor–recipient size mismatch and survival after bilateral lung transplantation

The Journal of heart and lung transplantation, 2012-11, Vol.31 (11), p.1207-1213.e7

2012

Volltextzugriff (PDF)

Pulmonary Hypertension due to Lung Disease and/or Hypoxia

Clinics in chest medicine, 2013-12, Vol.34 (4), p.695-705

2013

Volltextzugriff (PDF)

Comparison of wait times and mortality for idiopathic pulmonary fibrosis patients listed for single or bilateral lung transplantation

The Journal of heart and lung transplantation, 2010-10, Vol.29 (10), p.1165-1171

2010

Volltextzugriff (PDF)

Idiopathic interstitial pneumonia-associated pulmonary hypertension: A target for therapy?

Respiratory medicine, 2017-01, Vol.122, p.S10-S13

2017

Volltextzugriff (PDF)

The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis

Respiratory medicine, 2006-10, Vol.100 (10), p.1734-1741

2006

Volltextzugriff (PDF)

Native Lung Complications in Single-lung Transplant Recipients and the Role of Pneumonectomy

The Journal of heart and lung transplantation, 2009-08, Vol.28 (8), p.851-856

2009

Volltextzugriff (PDF)

Genomic phenotype of non-cultured pulmonary fibroblasts in idiopathic pulmonary fibrosis

Genomics (San Diego, Calif.), 2010-09, Vol.96 (3), p.134-145

2010

Volltextzugriff (PDF)

Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study

The Journal of heart and lung transplantation, 2021-08, Vol.40 (8), p.822-830

2021

Volltextzugriff (PDF)

sGC stimulators: Evidence for riociguat beyond groups 1 and 4 pulmonary hypertension

Respiratory medicine, 2017-01, Vol.122, p.S28-S34

2017

Volltextzugriff (PDF)

Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD)

The Journal of heart and lung transplantation, 2021-06, Vol.40 (6), p.488-493

2021

Volltextzugriff (PDF)

Standardization of the 6-min walk test in clinical trials of idiopathic pulmonary fibrosis

Contemporary clinical trials, 2021-01, Vol.100, p.106227-106227, Article 106227

2021

Volltextzugriff (PDF)

Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosis

The American journal of pathology, 2015-04, Vol.185 (4), p.943-957

2015

Volltextzugriff (PDF)

Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury

The Journal of heart and lung transplantation, 2021-11, Vol.40 (11), p.1454-1462

2021

Volltextzugriff (PDF)

Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis

Respiratory medicine, 2015-07, Vol.109 (7), p.914-922

2015

Volltextzugriff (PDF)

Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension

Respiratory medicine, 2013-05, Vol.107 (5), p.778-784

2013

Volltextzugriff (PDF)

Categorization and impact of pulmonary hypertension in patients with advanced COPD

Respiratory medicine, 2010-12, Vol.104 (12), p.1877-1882

2010

Volltextzugriff (PDF)

The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry

Respiratory medicine, 2022-05, Vol.196, p.106801-106801, Article 106801

2022

Volltextzugriff (PDF)

Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry

Respiratory medicine, 2018-06, Vol.139, p.72-78

2018

Volltextzugriff (PDF)

Clinical features and allograft failure rates of pulmonary antibody-mediated rejection categories

The Journal of heart and lung transplantation, 2023-02, Vol.42 (2), p.226-235

2023

Volltextzugriff (PDF)

Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study – Rationale and study design

Respiratory medicine, 2018-05, Vol.138, p.13-20

2018

Volltextzugriff (PDF)

Ambrisentan response in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) – A subgroup analysis of the ARIES-E clinical trial

Respiratory medicine, 2016-08, Vol.117, p.254-263

2016

Volltextzugriff (PDF)

Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study

The Journal of heart and lung transplantation, 2021-06, Vol.40 (6), p.494-503

2021

Volltextzugriff (PDF)

1 – 25 von 212

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(209)
Mit Volltextzugriff
(202)

Publikationsform

Artikel
(212)

Sprache

Englisch
(212)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis

Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation

Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis

Parameters of donor–recipient size mismatch and survival after bilateral lung transplantation

Pulmonary Hypertension due to Lung Disease and/or Hypoxia

Comparison of wait times and mortality for idiopathic pulmonary fibrosis patients listed for single or bilateral lung transplantation

Idiopathic interstitial pneumonia-associated pulmonary hypertension: A target for therapy?

The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis

Native Lung Complications in Single-lung Transplant Recipients and the Role of Pneumonectomy

Genomic phenotype of non-cultured pulmonary fibroblasts in idiopathic pulmonary fibrosis

Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study

sGC stimulators: Evidence for riociguat beyond groups 1 and 4 pulmonary hypertension

Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD)

Standardization of the 6-min walk test in clinical trials of idiopathic pulmonary fibrosis

Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosis

Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury

Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis

Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension

Categorization and impact of pulmonary hypertension in patients with advanced COPD

The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry

Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry

Clinical features and allograft failure rates of pulmonary antibody-mediated rejection categories

Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study – Rationale and study design

Ambrisentan response in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) – A subgroup analysis of the ARIES-E clinical trial

Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study

Aktive Filter

Suchergebnisse filtern